Table 1.
≥ 75 years (n = 130) | 65–74 years (n = 189) | < 65 years (n = 332) | p | ||||
---|---|---|---|---|---|---|---|
n | Mean ± SD or % | n | Mean ± SD or % | n | Mean ± SD or % | ||
Age (years) | 130 | 80.0 ± 4.7 | 189 | 69.2 ± 2.9 | 332 | 54.5 ± 7.4 | 0.000* |
Height (cm) | 127 | 156.2 ± 9.6 | 187 | 161.0 ± 8.6 | 328 | 166.2 ± 8.8 | 0.000* |
Waist circumference (cm) | 80 | 85.7 ± 10.5 | 120 | 87.3 ± 9.6 | 193 | 89.9 ± 12.0 | 0.009* |
Duration of diabetes (days) | 111 | 121.4 ± 94.6 | 181 | 114.1 ± 78.4 | 308 | 95.4 ± 74.4 | 0.003* |
Sex (male) | 67 | 51.5 | 117 | 61.9 | 250 | 75.3 | 0.000* |
Smoking | 13 | 10.3 | 34 | 18.6 | 96 | 29.8 | 0.000* |
Alcohol consumption | 39 | 31.7 | 82 | 45.1 | 180 | 56.1 | 0.000* |
Retinopathy | 8 | 6.2 | 8 | 4.2 | 32 | 9.6 | 0.064 |
Arteriosclerosis obliterans | 6 | 4.6 | 21 | 11.1 | 28 | 8.4 | 0.122 |
Stroke | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0.288 |
Myocardial infarction | 7 | 5.4 | 5 | 2.6 | 6 | 1.8 | 0.108 |
Angina pectoris | 8 | 6.2 | 8 | 4.2 | 11 | 3.3 | 0.387 |
Cardiac failure | 5 | 3.8 | 2 | 1.1 | 4 | 1.2 | 0.102 |
Atrial fibrillation | 4 | 3.1 | 5 | 2.6 | 7 | 2.1 | 0.817 |
Diet/exercise therapy | 49 | 37.7 | 48 | 25.4 | 92 | 27.7 | 0.044* |
Low dose of glimepiride | 18 | 13.8 | 25 | 13.2 | 29 | 8.7 | 0.153 |
Medium dose of glimepiride | 9 | 6.9 | 21 | 11.1 | 20 | 6.0 | 0.104 |
BG | 9 | 6.9 | 25 | 13.2 | 65 | 19.6 | 0.002* |
TZD | 7 | 5.4 | 12 | 6.3 | 19 | 5.7 | 0.929 |
α-GI | 5 | 3.8 | 3 | 1.6 | 10 | 3.0 | 0.446 |
Multidrug therapy | 33 | 25.4 | 55 | 29.1 | 97 | 29.2 | 0.692 |
Antihypertensive drug | 81 | 62.3 | 106 | 56.1 | 144 | 43.4 | 0.000* |
Antihyperlipidemic drug | 62 | 47.7 | 94 | 49.7 | 156 | 47.0 | 0.832 |
Antihyperuricemic drug | 6 | 4.6 | 9 | 4.8 | 16 | 4.8 | 0.996 |
Antithrombogenic drug | 22 | 16.9 | 44 | 23.3 | 52 | 15.7 | 0.088 |
* p < 0.05